The plant in Hwaseong will make 200,000 microneedle patches a year for trials. Daewoong claims its patch tops 80% of the bioavailability of injections.
Recap by typeshit. Full story at Korea Biomedical Review.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
A basic primer that walks through how amino acid makeup shapes what a peptide does. Evergreen material with little that's new.
The Ministry of Health is asking the healthcare sector to promote careful use of weight and metabolic drugs, warning that misuse could carry risks.
Loading…